Skoči na glavni sadržaj

Pregledni rad

https://doi.org/10.37797/ig.40.4.5

Pulmonary Embolism in Pneumonia

Bea Hohšteter ; Medicinski fakultet Sveučilišta u Zagrebu, Hrvatska
Lidija Ljubičić orcid id orcid.org/0000-0003-2493-4847 ; Klinika za plućne bolesti Jordanovac, Klinički bolnički centar Zagreb, Hrvatska
Gordana Pavliša ; Medicinski fakultet Sveučilišta u Zagrebu; Klinika za plućne bolesti Jordanovac, Klinički bolnički centar Zagreb, Hrvatska


Puni tekst: hrvatski pdf 193 Kb

str. 148-153

preuzimanja: 880

citiraj

Puni tekst: engleski pdf 193 Kb

str. 148-153

preuzimanja: 283

citiraj


Sažetak

Pneumonia and pulmonary embolism (PE) share common risk factors, radiological findings and one disease may induce the development of another. The clinical characteristics of pneumonia can completely mask the concomitant PE, which, along with the increase in D-dimer due to inflammatory events, significantly complicates the screening of patients who need imaging diagnostic methods. A specific feature (including the exact D-dimer cut-off value), which would clearly indicate concomitant PE in pneumonia has not yet been established. However, older age, comorbidities, chest pain, dyspnea and syncope are more common in pneumonia with coexisting PE than in pneumonia alone. In new coronavirus associated pneumonia (COVID-19), PE is far more frequent than in pneumonia caused by other microorganisms. PE in COVID-19 pneumonia is associated with risk factors such as male sex, higher levels of C-reactive protein and delayed hospitalization. Anticoagulant-prophylaxis reduces the incidence of PE in COVID-19 pneumonia.

Ključne riječi

pulmonary embolism; pneumonia; D-dimers; COVID-19; anticoagulants

Hrčak ID:

254023

URI

https://hrcak.srce.hr/254023

Datum izdavanja:

18.3.2021.

Podaci na drugim jezicima: hrvatski

Posjeta: 2.558 *